Cécile Déjou

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 404 citations · Full text

Cancer Immunosurveillance, Medicine, Immune Checkpoint Inhibitors +15

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 237 citations

Cd39 Enzymatic Function, T-regulatory Cell, Immunology +25

CCL20 and β-Defensin-2 Induce Arrest of Human Th17 Cells on Inflamed Endothelium In Vitro under Flow Conditions

Soufiane Ghannam, Cécile Déjou, Nathalie Pedretti et al. · The Journal of Immunology · 2010 · 68 citations · Full text

Ccr6 Expression, Immunology, Immune Regulation +26

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway

Emilie Laprévotte, Stéphanie Cochaud, Stanislas du Manoir et al. · Oncotarget · 2017 · 52 citations · Full text

Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer

Ghita Chabab, Clément Barjon, Naoill Abdellaoui et al. · Journal of Leukocyte Biology · 2020 · 47 citations

T-regulatory Cell, Immunology, Immune Regulation +23